# BEPOTASTINE BESILATE
> **ANDA217770** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2024-08-14
## Drug
- **FDA Application Number:** ANDA217770
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BEPOTASTINE BESILATE
- **Generic name:** BEPOTASTINE BESILATE
- **Active ingredients:** BEPOTASTINE BESILATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2024-08-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217770)
---
*AI Analytics · CC0 1.0*